Great to hear from you again Hillman787. Your silence was worrying. From memory, you have about 100,000 shares. We are small fry with 11,000 having sold a few at 10.00 to be cost-free. As I see it, the only change (and it is a big one) is the time frame in the Scoping Study. I would like to see them go back to scratch and start again. With hard hats on and less obsession with bloody computer modelling. Get approval for a small-scale pilot plant and target the best stuff first. Put the horse before the cart. Less capex too. Am thinking we might top up at around 2.50 but it may be hard to persuade the most important person in my life. We happen to be in Rome and shoes are very much at the top of the agenda. Quite right too. We are within walking distance of a small family-owned and run shoe shop on the via Ripeta. Old friends now. Maybe I could exercise my discretion and buy some more "shoes " on Monday without overloading anyone with too much information.
- Forums
- ASX - By Stock
- Ann: Gonneville Nickel-Copper-PGE Project Scoping Study
Great to hear from you again Hillman787. Your silence was...
-
-
- There are more pages in this discussion • 219 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
-0.035(2.30%) |
Mkt cap ! $577.7M |
Open | High | Low | Value | Volume |
$1.48 | $1.56 | $1.46 | $5.624M | 3.772M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65961 | $1.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 20387 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65961 | 1.480 |
2 | 29750 | 1.475 |
1 | 14750 | 1.470 |
1 | 14750 | 1.465 |
3 | 17750 | 1.460 |
Price($) | Vol. | No. |
---|---|---|
1.495 | 20387 | 1 |
1.500 | 2553 | 1 |
1.505 | 14750 | 1 |
1.510 | 14750 | 1 |
1.515 | 69411 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CHN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online